![]() |
|
|
Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA 956168741; a Department of Pharmacological Sciences, Health Sciences Center, State University of New York at Stony Brook, Stony Brook, NY 117948651; and b Cardiovascular Research Institute and c Department of Anatomy, University of California, San Francisco, CA 941430130
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: apolipoproteinB100 liver kidney ultrastructure yolk deposition
| INTRODUCTION |
|---|
|
|
|---|
| TRIGLYCERIDE DEPOSITION INTO OVARIAN YOLK FOLLICLES |
|---|
|
|
|---|
Yolk deposition is continuous, and yolk follicles increase in size from
7 to 35 mm in diameter and in weight from 0.2 to 17 g in the 710
d preceding ovulation (Etches 1996
). Interestingly, ultrastructural
studies of the granulosa basal lamina surrounding the oocyte indicated
that this membrane acts as a selective mechanical sieve to circulating
generic VLDL (Griffin and Perry 1985
). Only those apoB-lipoproteins
(apoB-LP) with diameters of 2544 nm were observed distal to the
granulosa basal lamina. These results suggest that only a select size
subclass of apoB-LP can access oocytic receptors.
During classical apoB-LP metabolism, lipoprotein lipase (LPL) hydrolysis and other intravascular remodeling processes rapidly convert VLDL into intermediate (IDL) and low density lipoproteins containing substantial cholesteryl esters and reduced fractional triacylglycerol content. Thus, under typical VLDL metabolic conditions, apoB-LP with diameters sufficiently small to pass through the granulosa basal lamina (i.e., IDL and LDL) are unable to provide sufficient energy for embryonic growth and development (Table 1 ).These findings indicate that significant changes in generic VLDL assembly and metabolism must have evolved to permit small energy-laden VLDLy to deposit nutritionally adequate egg yolk.
|
| VLDLy, A SPECIAL CLASS OF VLDL FOR YOLK DEPOSITION |
|---|
|
|
|---|
|
|
| HOW DOES VLDLy GET SMALL? |
|---|
|
|
|---|
Apolipoprotein VLDL-II and apoB are rapidly induced by exogenous
estrogen in the rooster liver and accumulate within the VLDL fraction
in an approximately equal mass ratio (Williams 1979
). On the basis of
the known molecular weights of apoB and apoVLDL-II, the VLDL fraction
contains ~46 apoVLDL-II molecules per apoB. Each VLDL particle
contains a single apoB and most of the apoVLDL-II is recovered as a
disulfide-linked dimer. Hence, the VLDLy particles that accumulate in
response to estrogen appear to contain 1 apoB and 23 apoVLDL-II. To
test directly that apoB and apoVLDL-II are present on the same VLDL
particles, an estrogen-treated rooster was injected with
3H-leucine, and 3H-VLDL was isolated. The
isolated VLDL underwent reaction with antibodies to apoB and to
apoVLDL-II to determine how much of the apoVLDL-II was
co-immunoprecipitated by anti-apoB and, conversely, how much of the
apoB was co-immunoprecipitated by anti-apoVLDL-II. The antibodies were
shown to be free of reactivity toward the other apolipoprotein (Blue and Williams 1981
, Williams 1979
) but would be expected to precipitate
the other apolipoprotein if it were present in the same VLDL particle.
The results in Table 3
show that each antibody was able to precipitate 86100% of the other
apolipoprotein in native VLDLy. Furthermore, the distribution of
radioactivity between apoB and apoVLDL-II in the immunoprecipitate
formed with either antibody was the same as in native VLDL. This latter
result confirms that apoB or apoVLDL-II is co-immunoprecipitated by
virtue of residence in the same VLDLy particle. These results indicate
that the great majority of VLDL particles present in blood plasma after
estrogen treatment contain both apoVLDL-II and apoB in the same VLDLy
particle.
|
The reduced particle diameter of VLDLy could result from a
relatively greater estrogen-induced increase in apoB synthesis compared
with triacylglycerol synthesis. With less core lipid available for each
molecule of apoB protein, particle size could be expected to decline.
However, this is not an adequate explanation because VLDLy particle
diameter continued to be a highly regulated physical property in hens
sufficiently overfed to produce a fatty liver (Walzem et al. 1993
).
Overfed egg-laying hens allowed only a 22% increase in VLDLy particle
diameter, from 27 to 33 nm (Walzem et al. 1994
). How VLDLy particle
diameter is downsized in the setting of surplus lipid substrates is
under active investigation because it is contrary to a major paradigm
of apoB biology.
| WHY DOES AVIAN KIDNEY SECRETE GENERIC VLDL? |
|---|
|
|
|---|
|
|
| HOW ARE VLDLy ASSEMBLED? |
|---|
|
|
|---|
A basic tenet of our hypothesis of the two-step process of apoB
core-lipidation is that a second-step triacylglycerol-rich particle of
nascent VLDL size is formed independently of apoB within the lumen of
the ER (Hamilton 1994
). To further test this hypothesis in a different
but well-defined setting, we examined absorptive enterocytes of the
duodenum of mice at 19 d gestation (i.e., before intestinal
exposure to food) and during the first hours of sucking mother's milk.
The novelty of this experiment is that we characterized the
ultrastructural appearance of these cells that normally secrete
chylomicrons in mice that were genetically engineered to be deficient
in apoB expression in the intestine. In the virtual absence of apoB
expression in the intestines, triacylglycerol-rich particles of nascent
VLDL size (19-d gestational) and of chylomicron size (first fatty meal)
continued to be assembled within the lumen of the enterocyte ER, but
very few triacylglycerol-rich particles entered the Golgi apparatus and
even fewer reached the extracellular space (Hamilton et al. 1998
).
Thus, the ability of an absorptive enterocyte to assemble a
triacylglycerol-rich particle of VLDL or chylomicron size within the ER
lumen without the requirement for apoB is a compelling argument
supporting the two-step hypothesis.
We have biochemically addressed the question of whether second-step triacylglycerol-rich particles of VLDL size that lack apoB can be isolated from the ER. We developed a novel technique to rapidly recover large amounts of mainly uncontaminated rough ER membranes to determine the biochemical properties of both first-step (small apoB-containing particles) and second-step particles (lacking apoB) isolated from the lumen of the ER (Hamilton, R. L., unpublished ). We compared the putative first- and second-step particles that were isolated from rat liver rough ER fractions (mainly apoB48) to similar particles from rough ER fractions of the liver of the laying hen (apoB100 only). The first-step apoB-containing particles from rat liver rough ER consisted mainly of apoB48 together with lesser amounts of apoB100 and contained both of the core lipids. In contrast, the first-step particle fraction from the rough ER of the laying hen liver consisted only of apoB100, and the core lipids were almost exclusively triacylglycerol, consistent with the lipid profile of the laying hen's liver Golgi nascent VLDLy and plasma VLDLy compositions. The most interesting finding of these preliminary studies was the isolation of putative second-step triacylglycerol-rich particles that were biochemically shown to lack apoB in both rat and hen. Those particles lacking apoB48 from the rat liver rough ER matched the size distribution (~3585 nm) of rat liver Golgi nascent VLDL containing mainly apoB48, whereas those lacking apoB100 from the laying hen liver matched the size distribution (~2545 nm) of laying hen Golgi nascent VLDLy containing only apoB100.
These results strongly suggest that both apoB48 and apoB100 isoforms obtain most of their core lipids during VLDL assembly from a second-step mechanism by synthesizing a triacylglycerol-rich particle of nascent VLDL diameter within the lumen of the ER independent of apoB. We also hypothesize that the two-step mechanism of apoB-core lipidation is an ancient feature of apoB biology because oviparous species preceded mammals in evolution.
| FOOTNOTES |
|---|
1 Presented at the symposium "Assembly and
Physiology of Apolipoprotein B-Containing Lipoproteins It's Not Just
for Heart Disease Anymore!" as part of Experimental Biology 98, April
1822, 1998, San Francisco, CA. The symposium was sponsored by the
Energy and Macronutrient Research Interest Section of the American
Society for Nutritional Sciences, the Egg Nutrition Center, the
American Heart Association-Western States Affiliate, Merck Research
Laboratories, Bristol-Meyers Squibb Pharmaceutical Research Institute
and Parke-Davis Pharmaceutical Research. Published as a supplement to
The Journal of Nutrition. Guest editors for this supplement
were Rosemary L. Walzem, University of California, Davis, and Robert L.
Hamilton, University of California, San Francisco, CA. ![]()
2 Supported by American Heart
Association-Grant-in-Aid #97218 (R.L.H. and R.L.W.), U.S. Department
of Agriculture Formula Funds provided through the School of Veterinary
Medicine (R.J.H. and R.L.W.), UCSF-ASFRG (R.L.H.) and National
Institiutes of Health grant HL32868 (D.L.W.). ![]()
3 Abbreviations used: apo, apolipoprotein;
apoB-LP, apolipoprotein Bcontaining lipoproteins; apoVLDL-II,
apolipoprotein VLDL-II; ER, endoplasmic reticulum; IDL, intermediate
density lipoprotein; LPL, lipoprotein lipase; MTP, microsomal
triglyceride transfer protein; VLDLy, yolk targeted VLDL. ![]()
| REFERENCES |
|---|
|
|
|---|
1.
Alexander C. A., Hamilton R. L., Havel R. J.. Subcellular localization of B apoprotein of plasma lipoproteins in rat liver. J. Cell Biol. 1976;69:241-263.
2. Bacon W. L., Leclercq B., Blum J. C.. Difference in metabolism of very low density lipoprotein from laying chicken hens in comparison to immature chicken hens. Poult. Sci. 1978;57:1675-1686.[Medline]
3. Bacon W. L., Musser M. A., Brown K. I.. Plasma free fatty acid and neutral lipid concentrations in immature, laying and broody turkey hens. Poult. Sci. 1974;53:1154-1160.[Medline]
4. Benson J. D., Bensadoun A., Cohen D.. Lipoprotein lipase of ovarian follicles in the domestic chicken (Gallus domesticus). Proc. Soc. Exp. Biol. Med. 1975;148:347-350.[Medline]
5.
Blue M.-L., Protter A. A., Williams D. L.. Biosynthesis of apolipoprotein B in rooster kidney, intestine, and liver. J. Biol. Chem. 1980;255:10048-10051.
6. Blue M.-L., Williams D. L.. Induction of avian serum apolipoprotein II and vitellogenin by tamoxifen. Biochem. Biophys. Res. Commun. 1981;98:785-791.[Medline]
7.
Borén J., Rustaeus S., Olofsson S.-O.. Studies on the assembly of apolipoprotein B-100- and B-48-containing very low density lipoproteins in McA-RH7777 cells. J. Biol. Chem. 1994;269:25879-25888.
8. Bujo H., Hermann M., Lindstedt K. A., Nimpf J., Schneider W. J.. Low density lipoprotein receptor gene family members mediate yolk deposition. J. Nutr. 1997;127:801S-804S.
9. Capony F., Williams D. L.. Apolipoprotein B of avian very low density lipoproteincharacteristics of its regulation in nonstimulated and estrogen-stimulated rooster. Biochemistry 1980;19:2219-2226.[Medline]
10. Chan L., Jackson R. L., O'Malley B. W., Means A. R.. Synthesis of very low density lipoproteins in the cockerelEffects of estrogen. J. Clin. Investig. 1976;58:368-379.
11. Chapman M. J., Goldstein S., Laudat M. H.. Characterization and comparative aspects of the serum very low and low density lipoproteins and their apoproteins in the chicken (Gallus domesticus). Biochemistry 1977;16:3006-3015.[Medline]
12. Chen S.-E., Bacon W.L., Nestor K. E., Meuniot V. L., Hansen R. J., Walzem R. L., Bacon W. L.. Characterization of plasma and yolk very low density lipoproteins (VLDL) from three lines of laying Japanese quail selected for plasma yolk precursor for 32 generations. Poult. Sci. 1997;76:34(abs).
13. Clifford C. K., Bensadoun A.. In vivo uptake of triglyceride fatty acids and free fatty acids by ovarian follicles of hens (Gallus domesticus). Comp. Biochem. Physiol. A 1975;51:133-137.[Medline]
14. Dashti N., Kelley J. L., Thayer R. H., Ontko J. A.. Concurrent inductions of avian hepatic lipogenesis, plasma lipids, and plasma apolipoprotein B by estrogen. J. Lipid Res. 1983;24:368-380.[Abstract]
15. Etches R. J.. Reproduction in Poultry 1996:135-140 CAB International Wallingford, UK.. .
16. Griffin H., Grant G., Perry M.. Hydrolysis of plasma triacylglycerol-rich lipoproteins from immature and laying hens (Gallus domesticus) by lipoprotein lipase in vitro. Biochem. J. 1982;206:647-654.[Medline]
17. Griffin H. D., Mitchell M. A.. A simple method for measuring albumin-bound non-esterified fatty acid concentration in laying-hen plasma. Comp. Biochem. Physiol. B 1984;78:219-222.[Medline]
18. Griffin H. D., Perry M. M.. Exclusion of plasma lipoproteins of intestinal origin from avian egg yolk because of their size. Comp. Biochem. Physiol. B 1985;82:321-325.[Medline]
19. Hamilton R. L.. Apolipoprotein-B-containing plasma lipoproteins in health and disease. Trends Cardiovasc. Med. 1994;4:131-139.
20. Hamilton R. L., Erikson S. K., Havel R. J.. Nascent VLDL assembly occurs in two steps in the endoplasmic reticulum (ER) of hepatocytes. Woodford F. P. Davignon J. Sniderman A. eds. Atherosclerosis X 1995:414-418 Elsevier Science Publishers Amsterdam, The Netherlands.. .
21. Hamilton R. L., Havel R. J.. Is microsomal triglyceride transfer protein the missing link in abetalipoproteinemia?. Hepatology 1993;18:460-463.[Medline]
22.
Hamilton R. L., Wong J. S., Cham C. M., Nielson B. L., Young S. G.. Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency. J. Lipid Res. 1998;39:1543-1557.
23. Heald P. J., Bandman H. G.. Lipid metabolism and the laying hen 1Plasma-free fatty acids and the onset of laying in the domestic fowl. Biochim. Biophys. Acta 1963;70:381-388.
24. Kirchgessner T. G., Heinzmann C., Svenson K. L., Gordon D. A., Nicosia M., Lebherz H. G., Lusis A. J., Williams D. L.. Regulation of chicken apolipoprotein Bcloning, tissue distribution, and estrogen induction of mRNA. Gene 1987;59:241-251.[Medline]
25. Kudzma D. J., St. Claire F., DeLallo L., Friedberg S. J.. Mechanism of avian estrogen-induced hypertriglyceridemiaevidence for overproduction of triglyceride. J. Lipid Res. 1975;16:123-133.[Abstract]
26. Kuksis A.. Yolk lipids. Biochim. Biophys. Acta 1992;1124:205-222.[Medline]
27. Lazier C. B., Wiktorowicz M., DiMattia G. E., Gordon D. A., Binder R., Williams D. L.. Apolipoprotein (apo) B and apoII gene expression are both estrogen-responsive in chick embryo liver but only apoII is estrogen-responsive in kidney. Mol. Cell. Endocrinol. 1994;106:187-194.[Medline]
28.
Luskey K. L., Brown M. S., Goldstein J. L.. Stimulation of the synthesis of very low density lipoproteins in rooster liver by estradiol. J. Biol. Chem. 1974;249:5939-5947.
29.
Miller K. W., Lane M. D.. Estradiol-induced alteration of very-low-density lipoprotein assemblyPossible competition among apoproteins for incorporation into nascent very-low-density lipoprotein. J. Biol. Chem. 1984;259:15277-15286.
30. Naber E. C.. Nutrient and drug effects on cholesterol metabolism in the laying hen. Fed. Proc. 1983;42:2486-2493.[Medline]
31. Nimpf J., George R., Schneider W. J.. Apolipoprotein specificity of the chicken oocyte receptor for low and very low density lipoproteinslack of recognition of apolipoprotein VLDL-II. J. Lipid Res. 1988;29:657-667.[Abstract]
32. Perry M. M., Gilbert A. B., Evans A. J.. Electron microscope observations on the ovarian follicle of the domestic fowl during the rapid growth phase. J. Anat. 1978;125:481-497.[Medline]
33.
Rustaeus S., Lindberg K., Borén J., Olofsson S.-O.. Brefeldin A reversibly inhibits the assembly of apoB containing lipoproteins in McA-RH7777 cells. J. Biol. Chem. 1995;270:28879-28886.
34. Rustaeus S., Lindberg K., Stillemark P., Claesson C., Asp L., Larsson T., Borén J., Olofsson S.-O.. Assembly of very low density lipoproteina two-step process of apolipoprotein B core lipidation. J. Nutr. 1999;129:463S-466S.
35.
Rustaeus S., Stillemark P., Lindberg K., Gordon D., Olofsson S.-O.. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells. J. Biol. Chem. 1998;273:5196-5203.
36. Schneider W. J., Carroll R., Severson D. L., Nimpf J.. Apolipoprotein VLDL-II inhibits lipolysis of triglyceride-rich lipoproteins in the laying hen. J. Lipid Res 1990;31:507-513.[Abstract]
37.
Spring D. J., Chen-Liu L. W., Chatterton J. E., Elovson J., Schumaker V. N.. Lipoprotein assemblyApolipoprotein B size determines lipoprotein core circumference. J. Biol. Chem. 1992;267:14839-14845.
38.
Tarugi P., Ballarinin G., Pinotti B., Franchini A., Ottaviani E., Calandra S.. Secretion of apoB- and apoA-1-containing lipoproteins by chick kidney. J. Lipid Res. 1998;39:731-743.
39. Walzem R. L.. Lipoproteins and the laying henform follows function. Poult. Avian Biol. Rev. 1996;7:31-64.
40. Walzem R. L., Davis P. A., Hansen R. J.. Overfeeding increases very low density lipoprotein diameter and causes the appearance of a unique lipoprotein particle in association with failed yolk deposition. J. Lipid Res. 1994;35:1354-1366.[Abstract]
41. Walzem R. L., Simon C., Morishita T., Lowenstine L., Hansen R. J.. Fatty liver hemorrhagic syndrome in hens overfed a purified dietSelected enzyme activities and liver histology in relation to liver hemorrhage and reproductive performance. Poult. Sci. 1993;72:1479-1491.[Medline]
42.
Walzem R. L., Watkins S., Frankel E. N., Hansen R. J., German J. B.. Older plasma lipoproteins are more susceptible to oxidationa linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease. Proc. Natl. Acad. Sci. U.S.A. 1995;92:7460-7464.
43. Williams D. L.. Apoproteins of avian very low density lipoproteindemonstration of a single high molecular weight apoprotein. Biochemistry 1979;18:1056-1063.[Medline]
This article has been cited by other articles:
![]() |
M. M. W. Smolenaars, O. Madsen, K. W. Rodenburg, and D. J. Van der Horst Molecular diversity and evolution of the large lipid transfer protein superfamily J. Lipid Res., March 1, 2007; 48(3): 489 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nilsson and R.-D. Duan Absorption and lipoprotein transport of sphingomyelin J. Lipid Res., January 1, 2006; 47(1): 154 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Boyle-Roden and R. L. Walzem Integral apolipoproteins increase surface-located triacylglycerol in intact native apoB-100-containing lipoproteins J. Lipid Res., August 1, 2005; 46(8): 1624 - 1632. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||